Banced Corp’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-12,930
Closed -$457K 13
2018
Q4
$457K Sell
12,930
-1,395
-10% -$50.6K 0.99% 38
2018
Q3
$552K Sell
14,325
-2,012
-12% -$70.3K 0.94% 42
2018
Q2
$534K Sell
16,337
-2,233
-12% -$67.3K 0.91% 41
2018
Q1
$508K Sell
18,570
-122
-0.7% -$3.32K 0.9% 44
2017
Q4
$463K Buy
18,692
+1,786
+11% +$49.3K 0.77% 59
2017
Q3
$493K Sell
16,906
-1,527
-8% -$42.2K 0.86% 48
2017
Q2
$511K Sell
18,433
-1,728
-9% -$45.9K 0.94% 46
2017
Q1
$502K Sell
20,161
-2,097
-9% -$51K 0.92% 44
2016
Q4
$482K Buy
22,258
+671
+3% +$14.6K 0.91% 46
2016
Q3
$514K Buy
+21,587
New +$515K 1.01% 35
2016
Q2
Sell
-30,480
Closed -$573K 116
2016
Q1
$573K Buy
+30,480
New +$535K 1% 40
2014
Q3
Sell
-15,126
Closed -$193K 181
2014
Q2
$193K Sell
15,126
-6,302
-29% -$81.9K 0.23% 177
2014
Q1
$290K Buy
21,428
+6,560
+44% +$86.1K 0.3% 144
2013
Q4
$179K Sell
14,868
-453
-3% -$5.35K 0.18% 176
2013
Q3
$180K Buy
+15,321
New +$166K 0.18% 173

Other funds holding BSX

Banced Corp's BSX Position: Q1 2019 in Review

Banced Corp sold out of Boston Scientific (BSX) in Q1 2019, closing a stake of 12,930 shares — an estimated $457K sold.

Banced Corp first reported a position in BSX in Q3 2013 and held it in 15 quarters. The position peaked at $573K in Q1 2016. 788 funds tracked by Wall St. Rank hold BSX as of Q1 2019.

  • Banced Corp reported no remaining Boston Scientific position as of Q1 2019 after selling out during the quarter.
  • Banced Corp sold 12,930 Boston Scientific shares in Q1 2019, an estimated $457K.
  • Banced Corp first reported a position in Boston Scientific in Q3 2013 and held it in 15 quarters.
  • Banced Corp's Boston Scientific position peaked at $573K in Q1 2016.
  • 788 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2019.

Based on Banced Corp's 13F filing for Q1 2019.